2025
Trends of attrition and migration in academic radiology in U.S. medical schools
Malhotra A, Futela D, Ebrahimian S, Kandala K, Gandhi D, Payabvash S, Mohan S. Trends of attrition and migration in academic radiology in U.S. medical schools. Journal Of The American College Of Radiology 2025 PMID: 39892798, DOI: 10.1016/j.jacr.2025.01.013.Peer-Reviewed Original ResearchMedical schoolsPrimary cohortAttrition ratesUS medical schoolsU.S. medical schoolsWorkforce shortagesClinical facultyRetention rateAssess trendsFull-time facultyFaculty appointmentsLongitudinal trendsAcademic radiologySecondary cohortAcademic radiology departmentsEnd pointsCohortStudy periodAttritionWomenRadiology departmentRadiology facultyRadiologyProfessor rankIndependent variables
2023
Combined Value of Dimensionless Index and Transvalvular Flow Rate in Risk Stratification of Aortic Stenosis
Namasivayam M, Churchill T, Capoulade R, Pibarot P, Danik J, Picard M, Levine R, Hung J. Combined Value of Dimensionless Index and Transvalvular Flow Rate in Risk Stratification of Aortic Stenosis. The American Journal Of Cardiology 2023, 213: 69-71. PMID: 38103765, PMCID: PMC10842843, DOI: 10.1016/j.amjcard.2023.12.008.Peer-Reviewed Original ResearchHigher Procedural Volumes Are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute Ischemic Stroke
Nogueira R, Haussen D, Smith E, Sun J, Xian Y, Alhanti B, Blanco R, Mac Grory B, Doheim M, Bhatt D, Fonarow G, Hassan A, Joundi R, Mocco J, Frankel M, Schwamm L. Higher Procedural Volumes Are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute Ischemic Stroke. Annals Of Neurology 2023, 95: 146-155. PMID: 37731004, DOI: 10.1002/ana.26803.Peer-Reviewed Original ResearchHigh procedural volumeProcedural volumeEndovascular therapyHospital mortalityPrimary cohortAIS patientsFaster treatment timesAcute ischemic stroke patientsGood discharge outcomeGuidelines-Stroke registryPretreatment National InstitutesHealth Stroke ScaleAcute ischemic strokeIschemic stroke patientsObservational cohort studyHospital procedural volumeLower ratesStroke ScaleCohort studyIschemic strokeArterial punctureDischarge outcomesEndovascular treatmentInterhospital transferStroke patients
2021
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations
Xu J, Keenan TE, Overmoyer B, Tung NM, Gelman RS, Habin K, Garber JE, Ellisen LW, Winer EP, Goss PE, Yeap BY, Chabner BA, Isakoff SJ. Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations. Breast Cancer Research And Treatment 2021, 189: 641-651. PMID: 34417675, DOI: 10.1007/s10549-021-06292-7.Peer-Reviewed Original ResearchConceptsObjective response rateClinical benefit rateProgression-free survivalMedian progression-free survivalMetastatic breast cancer patientsPhase II trialMetastatic breast cancerBreast cancer patientsBRCA1/2 carriersBreast cancerExpansion cohortII trialPrimary endpointPrimary cohortCancer patientsBenefit rateBRCA1/2 mutationsDay 1Longer median progression-free survivalSingle-arm phase II trialCommon grade 3Doses of veliparibPlatinum-naïve patientsPrior platinum therapyBRCA mutation carriersThe Economic Impact of Extensor Tendon Lacerations of the Hand in the United States
Mehrzad R, Mookerjee V, Schmidt S, Jehle C, Rao V, Mehrzad M, Liu P. The Economic Impact of Extensor Tendon Lacerations of the Hand in the United States. Annals Of Plastic Surgery 2021, 88: 168-172. PMID: 34176901, DOI: 10.1097/sap.0000000000002927.Peer-Reviewed Original ResearchConceptsExtensor tendon lacerationsTendon lacerationsTotal annual direct medical costsAnnual direct medical costsCommon hand conditionsIndirect costsDirect medical costsPrevalence-based costSignificant economic burdenHealth care systemPrimary cohortSurgical repairRehabilitation protocolMedical costsEconomic burdenIllness modelLevel IIHand conditionsInjuryLacerationCare systemPatientsThousands of AmericansUnited StatesTotal cost
2020
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
Correia C, Mawe S, Lofgren S, Marangoni RG, Lee J, Saber R, Aren K, Cheng M, Teaw S, Hoffmann A, Goldberg I, Cowper SE, Khatri P, Hinchcliff M, Mahoney JM. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision. Arthritis Research & Therapy 2020, 22: 48. PMID: 32171325, PMCID: PMC7071594, DOI: 10.1186/s13075-020-2127-0.Peer-Reviewed Original ResearchConceptsSystemic sclerosisFibrosis scoreQuantitative image featuresBiopsy scorePrimary cohortOutcome measuresSecondary cohortDiagnostic scoreSkin severity scoreSSc clinical trialsRodnan skin scoreLogistic regression modelsControl biopsiesRegression modelsSkin scoreSeverity scoreClinical hallmarkClinical trialsForearm biopsiesSSc skinBiopsy sectionsIndependent cohortPatient basisSSc biopsiesCollagen deposition
2019
Baseline Characteristics of the VANISH Cohort
Axelsson Raja A, Shi L, Day SM, Russell M, Zahka K, Lever H, Colan SD, Margossian R, Hall EK, Becker J, Jefferies JL, Patel AR, Choudhury L, Murphy AM, Canter C, Bach R, Taylor M, Mestroni L, Wheeler MT, Benson L, Owens AT, Rossano J, Lin KY, Pahl E, Pereira AC, Bundgaard H, Lewis GD, Vargas JD, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Orav EJ, Braunwald E, Ho CY. Baseline Characteristics of the VANISH Cohort. Circulation Heart Failure 2019, 12: e006231. PMID: 31813281, PMCID: PMC7219518, DOI: 10.1161/circheartfailure.119.006231.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAngiotensin II Type 1 Receptor BlockersBrazilCanadaCardiomyopathy, HypertrophicChildDenmarkDisease ProgressionDouble-Blind MethodFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedMutationPhenotypeRecovery of FunctionSarcomeresTime FactorsTreatment OutcomeUnited StatesValsartanYoung AdultConceptsAngiotensin receptor blockersHypertrophic cardiomyopathyReceptor blockersBaseline characteristicsImaging abnormalitiesPrimary cohortMutation carriersNew York Heart Association class IINew York Heart Association classFunctional class II symptomsOlder ageClass II symptomsNonobstructive hypertrophic cardiomyopathyNormal functional capacityPrevious trialsVentricular wall thicknessPeak oxygen consumptionPlacebo-controlled designCardiac magnetic resonanceGene mutation carriersLate gadolinium enhancementVANISH trialAdvanced diseaseAssociation classVentricular hypertrophyThe Economic Impact of Flexor Tendon Lacerations of the Hand in the United States.
Mehrzad R, Mookerjee V, Schmidt S, Jehle C, Kiwanuka E, Liu P. The Economic Impact of Flexor Tendon Lacerations of the Hand in the United States. Annals Of Plastic Surgery 2019, 83: 419-423. PMID: 31524735, DOI: 10.1097/sap.0000000000001950.Peer-Reviewed Original ResearchConceptsFlexor tendon lacerationsTendon lacerationsIndirect costsCommon hand conditionsPrevalence-based costImportant economic burdenTotal direct costsHealth care systemAmerican Medical SystemsSurgical repairPrimary cohortRehabilitation protocolEconomic burdenLacerationEconomic impactIllness modelSecondary cohortInitial operationHand conditionsInjuryCare systemDirect costsPatientsThousands of AmericansCohortDuration of Operative Vaginal Delivery and Adverse Obstetric Outcomes
Miller E, Lai Y, Bailit J, Reddy U, Wapner R, Varner M, Thorp J, Leveno K, Caritis S, Prasad M, Tita A, Saade G, Sorokin Y, Rouse D, Blackwell S, Tolosa J. Duration of Operative Vaginal Delivery and Adverse Obstetric Outcomes. American Journal Of Perinatology 2019, 37: 503-510. PMID: 30895577, PMCID: PMC6754310, DOI: 10.1055/s-0039-1683439.Peer-Reviewed Original ResearchConceptsComposite adverse neonatal outcomeAdverse neonatal outcomesOperative vaginal deliveryNeonatal outcomesVaginal deliveryMulticenter observational cohortAdverse obstetric outcomesSevere perineal lacerationsObstetric outcomesPerinatal outcomesObservational cohortPerineal lacerationsPrimary cohortForceps applicationPotential confoundersSecondary analysisStrong associationOutcomesWomenCohortDurationDeliveryLacerationConfoundersForceps
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply